Myleran and pulmonary toxicity Patient Reports February 11, 2012

Myleran Side Effects Report #4749068-3
Myleran side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 10, 2005. Female patient, 64 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, pneumonitis, pulmonary toxicity, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE, ANTIBIOTICS, CORTICOSTEROID. Patient died.

Myleran Side Effects Report #4749070-1
Myleran side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 10, 2005. Male patient, 61 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: blood immunoglobulin g decreased, cough, influenza, lung infiltration, pneumonitis, pulmonary toxicity, respiratory failure, sepsis , streptococcal infection . Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with MELPHALAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.

Myleran Side Effects Report #4749071-3
Myleran side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 10, 2005. Male patient, 58 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: pneumonitis, pulmonary toxicity, pyrexia, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.